OKT3® (Monoclonal Antibody)


OKT3 is an immunosuppressive medicine that helps prevent organ rejection.


Administered intravenously only.

Adults: Usually receive 5 to 10mg per day over 7 to 14 days.
Children: Usually receive 2.5 to 5mg per day over 7 to 14 days.


The transplant team orders the medication and it will be administered by the physician during your hospitalization, or in the Comprehensive Transplant Center after your discharge.

Common Side Effects

Fever, chills, flu-like symptoms, shortness of breath, headache, lowered blood pressure, joint pain, diarrhea.